Dr Kevin Johnson formally joins Index Ventures
Following a six-year association with the venture investor as an advisor, life sciences specialist and entrepreneur Dr Kevin Johnson has joined Index Ventures as a Partner.
Dr Johnson, whose biotech career began 20 years ago with Cambridge Antibody Technology, joins Index Ventures's life sciences team specifically to seek out new assets in the biologics field. He will be based in the group's London office.
More on People
CapMan Managing Partner Johan Pålsson to depart
PУЅlsson resigns from management effective immediately; to stay as buyout partner until February 2024
Capvis grapples with EUR 1bn fundraise amid team exodus
Five partners for the Swiss-based GP leave firm in last two years; sponsor started sixth buyout fundraise in early 2023
Golding adds insurance expertise with hire for institutional clients team
Tim Ickenroth joins as director with prior experience at BNP Paribas and UniCredit
Travers Smith bolsters funds practice with hire from Proskauer
Tosin Adeyeri joins with particular experience in secondary portfolio transactions
Latest News
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Czech Republic-headquartered family office is targeting DACH and CEE region deals
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Ex-Rocket Internet leader Bettina Curtze joins Swiss VC firm as partner and CFO
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Estonia-registered VC could bolster LP base with fresh capital from funds-of-funds or pension funds